NRP1 and cancer: In this regard, the presence of ACE2 receptors and NRP-1 in different tissues could be beneficially seen as a prognostic marker in patients with certain cancer types and in favor of the usage of SARS-CoV-2 as an oncolytic agent, which will be discussed in a later section of this review.